AllCells Blog Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter

The success of chimeric antigen receptor (CAR)-T cell therapy has spurred interest in applying CAR technology to other immune cells in hopes of addressing some known limitations. With their intrinsic [...]The post Advancing CAR-NK Therapy: Why Leukopak Quality and Donor Characterization Matter appeared first on AllCells.